Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Stockton
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Stockton, CA

Studies commonly pay $75 to $4,500 per completed study

100 clinical trials are currently recruiting participants within 30 miles of Stockton. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

100studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Stockton right now

Top 25 of 100 recruiting studies, sorted by proximity — each links to its official registry page

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought
Memorial Medical Center — Modesto, California (28.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04510597)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06418204)

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

SpO2 N/A Interventional 100 participants sought
Paradigm Clinical Research — Modesto, California (28.9 mi) · Sponsor: Masimo Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07223177)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Memorial Medical Center — Modesto, California (28.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Memorial Medical Center — Modesto, California (28.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,260 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06931340)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought
Clinical Trial Site — Stockton, California (1.7 mi) · Sponsor: Alnylam Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07181109)

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Intracerebral Hemorrhage, Atrial Fibrillation Phase 3 Interventional 700 participants sought
Doctors Medical Center Modesto, Modesto, CA — Modesto, California (28.9 mi) · Sponsor: Yale University
See eligibility & contact on ClinicalTrials.gov (NCT03907046)

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1 Phase 3 Interventional 150 participants sought
Paradigm Clinical Research - Modesto — Modesto, California (28.9 mi) · Sponsor: vTv Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06334133)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06498635)

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Age-related Macular Degeneration (AMD), Geographic Atrophy (GA) Phase 3 Interventional 975 participants sought
Retinal Consultants Medical Group Inc Modesto — Modesto, California (28.9 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06541704)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Phase 3 Interventional 228 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06992427)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Memorial Medical Center — Modesto, California (28.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06958328)

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Phase 2 Interventional 156 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06029270)

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos N/A Interventional 535 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07091617)

CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

Diabetic Macular Edema, DME Phase 3 Interventional 240 participants sought
Retinal Consultants Medical Group - Modesto — Modesto, California (28.9 mi) · Sponsor: EyePoint Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07449923)

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Colorectal Cancer Stage II, Colorectal Cancer Stage III Phase 3 Interventional 1,057 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT07018869)

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 147 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06317649)

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Obesity, Overweight Phase 3 Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Modesto, California (28.9 mi) · Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07654361)

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Phase 2 Interventional 146 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05408845)

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Phase 3 Interventional 1,978 participants sought
Memorial Medical Center — Modesto, California (28.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07391774)
Actively enrolling

Studies you may be able to join near Stockton

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Stockton

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

St Joseph's Cancer Institute - Dignity Health - St. Joseph's Medical Center

★ 5.0
1800 N California St, Stockton, CA 95204
(209) 467-6560

Central Valley Research

★ 4.9
400 E Orangeburg Ave Ste 5, Modesto, CA 95350
(209) 549-9538

Therapeutic Research Center

★ 3.7
10100 Trinity Pkwy Ste 115, Stockton, CA 95219
(209) 472-2240
"Used to have a great site, but now it is so glitchy I have to refresh 10 to 20 times just to take my CE or take the (required for completion) survey …"
— David A. Canfield, 2★

Sutter Institute for Medical Research: Sutter Medical Center, Sacramento

★ 4.5
2801 Capitol Ave #400, Sacramento, CA 95816
(916) 453-5898
"Nice and friendly, they called me at my appointment time. Not a lot of seating in the waiting room."
— stephen scharp, 4★

Clinical Trials Research

★ 5.0
3750 Auburn Blvd Ste A, Sacramento, CA 95821
(916) 487-8230
"I asked for a business location and it popped right up."
— Barbara McGarvey, 5★

UC Davis Health - Participate in Clinical Trials

2921 Stockton Blvd, Sacramento, CA 95817
(855) 823-1660

Sunwise Clinical Research

★ 4.7
1371 Oakland Blvd #301, Walnut Creek, CA 94596
(925) 298-5147
"They are a great group of people"
— Tree Sap, 5★

Center For Clinical Trials Of Sacramento, Inc.

7600 Hospital Dr G, Sacramento, CA 95823
(916) 525-3377

UC Davis Clinical and Translational Science Center

★ 1.8
2921 Stockton Blvd #2305, Sacramento, CA 95817
(916) 703-9184

Clinical trials in Stockton: what's recruiting

The Stockton area currently has 100 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Stockton, the most active research areas are:

  • Cancer & Oncology16 studies
  • Diabetes & Metabolism3 studies
  • Liver & Kidney1 studies
  • Heart & Vascular1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Stockton, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Stockton

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Stockton participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Stockton?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Stockton safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Stockton, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Stockton?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Stockton typically complete one or two studies per year.

Paid clinical trials near Stockton

Other metros within reach

Elk Grove, CA623 Modesto, CA99 Antioch, CA447 Sacramento, CA633 Concord, CA1,505 Fairfield, CA341 Roseville, CA634 Fremont, CA2,247

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Stockton Bladder Issues Due To Spinal Cord Injury in Stockton All conditions

More of CA

Long Beach3,366 Torrance3,258 Fullerton3,251 Anaheim3,193 Garden Grove3,186 Pomona3,148 Glendale2,964 Los Angeles2,949 Huntington Beach2,867 Santa Clarita2,384 Hayward2,257 Oakland2,248

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts